FMCQF
Fresenius Medical Care AG
Price Chart
Latest Quote
$45.17
+0.00 (+0.00%)
Current Price
| Previous Close | $45.17 |
| Open | $43.08 |
| Day High | $43.08 |
| Day Low | $43.01 |
| Volume | 2,000 |
Stock Information
Note: Financial values converted from EUR to USD
| Quarterly Dividend / Yield | $1.73 / 3.84% |
| Shares Outstanding | 268.56M |
| Quarterly Dividend Yield | 3.84% |
| Quarterly Dividend | $1.73 |
| Total Debt | $12.67B |
| Cash Equivalents | $1.42B |
| Revenue | $22.20B |
| Net Income | $1.08B |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $12.13B |
| P/E Ratio | 11.92 |
| EPS (TTM) | $3.79 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $22.90B |
| Sales | $22.20B |
| Income | $1.08B |
| Book/sh | $56.52 |
| Cash/sh | $4.61 |
| Employees | 108K |
Financial Ratios
| Quick Ratio | 0.74 |
| Current Ratio | 1.21 |
| Debt/Eq | 77.75 |
| EPS Growth TTM | -22.30% |
Returns & Margins
| ROA | 3.63% |
| ROE | 7.85% |
| Gross Margin | 25.96% |
| Operating Margin | 8.14% |
| Profit Margin | 4.88% |
Ownership
| Insider Ownership | 31.22% |
| Institutional Ownership | 49.07% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 0.80 |
| P/S | 0.63 |
| P/B | 0.80 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $44.22 |
| SMA50 | $43.76 |
| SMA200 | $47.36 |
| RSI | 100.00 |
| ATR | 0.2264 |
| Shares Float | 184.69M |
| Volatility | 0.81 |
Performance History
| Week | +0.00% |
| Month | +7.55% |
| Quarter | -8.21% |
| 6 Months | -2.90% |
| YTD | -2.90% |
| Year | -21.53% |
| 3 Years | +3.74% |
| 5 Years | -39.54% |
| 10 Years | -34.90% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $45.17 | 0 |
| 2026-06-17 | $45.17 | 0 |
| 2026-06-16 | $45.17 | 0 |
| 2026-06-15 | $45.17 | 0 |
| 2026-06-12 | $45.17 | 0 |
| 2026-06-11 | $45.17 | 0 |
| 2026-06-10 | $45.17 | 0 |
| 2026-06-09 | $45.17 | 0 |
| 2026-06-08 | $45.17 | 0 |
| 2026-06-05 | $45.17 | 0 |
| 2026-06-04 | $45.17 | 0 |
| 2026-06-03 | $45.17 | 0 |
| 2026-06-02 | $45.17 | 0 |
| 2026-06-01 | $45.17 | 200 |
| 2026-05-29 | $42.00 | 0 |
| 2026-05-28 | $42.00 | 0 |
| 2026-05-27 | $42.00 | 0 |
| 2026-05-26 | $42.00 | 0 |
| 2026-05-22 | $42.00 | 0 |
| 2026-05-21 | $42.00 | 0 |
| 2026-05-20 | $42.00 | 0 |
| 2026-05-19 | $42.00 | 0 |
About Fresenius Medical Care AG
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
đ° Latest News
FMS and Home Dialysis: How 5008X Could Reset Demand
Zacks âĸ 2026-06-08T18:51:00Z
FMS Launches kinexus Digital Platform for Home Dialysis Care
Zacks âĸ 2026-06-05T15:31:00Z
DaVita Expands Comprehensive Kidney Care Through Dialysis Services
Zacks âĸ 2026-06-04T17:41:00Z
DaVita Gains 21.4% in Three Months: How Should You Play the Stock?
Zacks âĸ 2026-06-03T17:26:00Z
Fresenius (FMS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-06-01T21:28:25Z
Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Weakness
Simply Wall St. âĸ 2026-05-29T13:08:03Z
Just Four Days Till Fresenius Medical Care AG (ETR:FME) Will Be Trading Ex-Dividend
Simply Wall St. âĸ 2026-05-17T06:02:19Z
Fresenius Medical Care's (ETR:FME) Solid Earnings Have Been Accounted For Conservatively
Simply Wall St. âĸ 2026-05-14T04:01:36Z
Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Simply Wall St. âĸ 2026-05-07T04:49:45Z
FMS Stock Rises Despite Q1 Earnings & Sales Miss, Margins Expand
Zacks âĸ 2026-05-06T15:39:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $14,579,257,000 | $14,528,612,000 | $14,504,328,000 | $12,845,656,000 |
| Cost Of Revenue | $14,579,257,000 | $14,528,612,000 | $14,504,328,000 | $12,845,656,000 |
| Total Revenue | $19,335,909,000 | $19,453,617,000 | $19,398,017,000 | $17,618,685,000 |
| Operating Revenue | $19,335,909,000 | $19,453,617,000 | $19,398,017,000 | $17,618,685,000 |
| Expenses | ||||
| Interest Expense | $407,044,000 | $424,640,000 | $360,139,000 | $353,599,000 |
| Total Expenses | $17,868,529,000 | $17,976,973,000 | $17,943,283,000 | $15,759,159,000 |
| Other Income Expense | $-74,985,000 | $-107,206,000 | $57,021,000 | $-7,236,000 |
| Net Non Operating Interest Income Expense | $-335,469,000 | $-336,423,000 | $-292,476,000 | $-280,429,000 |
| Interest Expense Non Operating | $407,044,000 | $424,640,000 | $360,139,000 | $353,599,000 |
| Operating Expense | $3,289,272,000 | $3,448,361,000 | $3,438,955,000 | $2,913,503,000 |
| Other Operating Expenses | $-37,040,000 | $20,055,000 | $39,961,000 | $-80,110,000 |
| Selling And Marketing Expense | $776,532,000 | $807,961,000 | $800,876,000 | - |
| General And Administrative Expense | $2,366,287,000 | $2,388,375,000 | $2,369,494,000 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $537,913,000 | $498,997,000 | $673,405,000 | $969,308,000 |
| Net Interest Income | $-335,469,000 | $-336,423,000 | $-292,476,000 | $-280,429,000 |
| Interest Income | $71,575,000 | $88,217,000 | $67,663,000 | $73,170,000 |
| Normalized Income | $685,024,860 | $661,351,619 | $789,028,420 | $1,046,404,380 |
| Net Income From Continuing And Discontinued Operation | $537,913,000 | $498,997,000 | $673,405,000 | $969,308,000 |
| Total Operating Income As Reported | $1,392,395,000 | $1,369,438,000 | $1,511,755,000 | $1,852,290,000 |
| Net Income Common Stockholders | $537,913,000 | $498,997,000 | $673,405,000 | $969,308,000 |
| Net Income | $537,913,000 | $498,997,000 | $673,405,000 | $969,308,000 |
| Net Income Including Noncontrolling Interests | $740,870,000 | $732,458,000 | $894,325,000 | $1,219,028,000 |
| Net Income Continuous Operations | $740,870,000 | $732,458,000 | $894,325,000 | $1,219,028,000 |
| Pretax Income | $1,056,926,000 | $1,033,015,000 | $1,219,279,000 | $1,571,861,000 |
| Special Income Charges | $-230,831,000 | $-208,164,000 | $-17,561,000 | $-1,882,000 |
| Earnings From Equity Interest | $134,875,000 | $121,785,000 | $214,761,000 | $92,175,000 |
| Interest Income Non Operating | $71,575,000 | $88,217,000 | $67,663,000 | $73,170,000 |
| Operating Income | $1,467,380,000 | $1,476,644,000 | $1,454,734,000 | $1,859,526,000 |
| Gross Profit | $4,756,652,000 | $4,925,005,000 | $4,893,689,000 | $4,773,029,000 |
| Per Share | ||||
| Diluted EPS | $1.83 | $1.70 | $2.30 | $3.31 |
| Basic EPS | $1.83 | $1.70 | $2.30 | $3.31 |
| Other | ||||
| Tax Effect Of Unusual Items | $-62,748,140 | $-66,636,381 | $-42,116,580 | $-22,314,620 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,416,087,000 | $3,438,617,000 | $3,575,521,000 | $3,648,547,000 |
| Total Unusual Items | $-209,860,000 | $-228,991,000 | $-157,740,000 | $-99,411,000 |
| Total Unusual Items Excluding Goodwill | $-209,860,000 | $-228,991,000 | $-157,740,000 | $-99,411,000 |
| Reconciled Depreciation | $1,742,257,000 | $1,751,971,000 | $1,838,363,000 | $1,623,676,000 |
| EBITDA (Bullshit earnings) | $3,206,227,000 | $3,209,626,000 | $3,417,781,000 | $3,549,136,000 |
| EBIT | $1,463,970,000 | $1,457,655,000 | $1,579,418,000 | $1,925,460,000 |
| Diluted Average Shares | $293,413,449 | $293,413,449 | $293,246,430 | $292,944,732 |
| Basic Average Shares | $293,413,449 | $293,413,449 | $293,246,430 | $292,944,732 |
| Diluted NI Availto Com Stockholders | $537,913,000 | $498,997,000 | $673,405,000 | $969,308,000 |
| Minority Interests | $-202,957,000 | $-233,461,000 | $-220,920,000 | $-249,720,000 |
| Tax Provision | $316,056,000 | $300,557,000 | $324,954,000 | $352,833,000 |
| Gain On Sale Of Ppe | $14,656,000 | $4,839,000 | $47,173,000 | $-8,628,000 |
| Gain On Sale Of Business | $-245,487,000 | $-213,003,000 | $-64,734,000 | $6,746,000 |
| Gain On Sale Of Security | $20,971,000 | $-20,827,000 | $-140,179,000 | $-97,529,000 |
| Research And Development | $183,493,000 | $231,970,000 | $228,624,000 | $220,782,000 |
| Selling General And Administration | $3,142,819,000 | $3,196,336,000 | $3,170,370,000 | $2,772,831,000 |
| Other Gand A | $2,366,287,000 | $2,388,375,000 | $2,369,494,000 | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,964,169,000 | $-2,392,074,000 | $-3,320,405,000 | $-3,122,187,000 |
| Total Assets | $33,566,579,000 | $33,929,808,000 | $35,754,114,000 | $34,366,558,000 |
| Total Non Current Assets | $25,643,835,000 | $25,228,397,000 | $27,550,659,000 | $26,399,316,000 |
| Other Non Current Assets | $198,325,000 | $223,576,000 | $198,794,000 | $924,614,000 |
| Non Current Deferred Assets | $229,509,000 | $283,953,000 | $312,679,000 | $315,360,000 |
| Non Current Deferred Taxes Assets | $229,509,000 | $283,953,000 | $312,679,000 | $315,360,000 |
| Investmentin Financial Assets | $795,856,000 | $611,584,000 | $615,796,000 | - |
| Goodwill And Other Intangible Assets | $16,540,732,000 | $16,012,335,000 | $17,309,858,000 | $15,820,970,000 |
| Other Intangible Assets | $1,370,080,000 | $1,362,327,000 | $1,518,677,000 | $1,459,393,000 |
| Current Assets | $7,922,744,000 | $8,701,411,000 | $8,203,455,000 | $7,967,242,000 |
| Other Current Assets | $217,681,000 | $332,612,000 | $358,034,000 | $342,892,000 |
| Hedging Assets Current | $24,088,000 | $18,593,000 | $19,777,000 | $3,417,000 |
| Assets Held For Sale Current | $161,013,000 | $507,600,000 | $0 | - |
| Restricted Cash | $29,240,000 | $26,467,000 | - | - |
| Prepaid Assets | $55,356,000 | $63,010,000 | $61,038,000 | $58,219,000 |
| Inventory | $2,067,922,000 | $2,179,175,000 | $2,296,214,000 | $2,038,014,000 |
| Receivables | $3,920,868,000 | $4,060,643,000 | $4,039,729,000 | $3,906,683,000 |
| Receivables Adjustments Allowances | $-206,439,000 | $-261,854,000 | $-168,681,000 | $-163,929,000 |
| Other Receivables | $228,647,000 | $360,046,000 | $104,448,000 | $84,886,000 |
| Taxes Receivable | $391,241,000 | $338,090,000 | $269,544,000 | $286,736,000 |
| Accrued Interest Receivable | $21,289,000 | $14,000,000 | $450,000 | - |
| Notes Receivable | $48,049,000 | $12,657,000 | $18,304,000 | $18,873,000 |
| Loans Receivable | $986,000 | $1,473,000 | $5,494,000 | $8,990,000 |
| Accounts Receivable | $3,396,159,000 | $3,430,932,000 | $3,670,098,000 | $3,508,766,000 |
| Cash Cash Equivalents And Short Term Investments | $1,446,576,000 | $1,513,311,000 | $1,428,663,000 | $1,618,017,000 |
| Cash And Cash Equivalents | $1,150,947,000 | $1,377,025,000 | $1,273,787,000 | $1,481,655,000 |
| Cash Equivalents | - | $324,429,000 | $362,772,000 | $556,521,000 |
| Cash Financial | - | $1,079,063,000 | $911,015,000 | $925,134,000 |
| Debt | ||||
| Net Debt | $5,687,260,000 | $6,527,441,000 | $7,239,776,000 | $7,089,113,000 |
| Total Debt | $10,978,908,000 | $12,050,412,000 | $13,192,326,000 | $13,320,149,000 |
| Long Term Debt And Capital Lease Obligation | $9,760,642,000 | $10,488,850,000 | $11,175,672,000 | $10,734,752,000 |
| Long Term Debt | $6,260,825,000 | $6,959,863,000 | $7,170,734,000 | $6,646,949,000 |
| Current Debt And Capital Lease Obligation | $1,218,266,000 | $1,561,562,000 | $2,016,654,000 | $2,585,397,000 |
| Current Debt | $577,382,000 | $944,603,000 | $1,342,829,000 | $1,923,819,000 |
| Other Current Borrowings | $575,441,000 | $487,771,000 | $698,140,000 | $745,575,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $17,798,066,000 | $19,103,273,000 | $20,304,935,000 | $20,387,521,000 |
| Total Non Current Liabilities Net Minority Interest | $12,138,006,000 | $12,991,683,000 | $13,837,621,000 | $13,129,887,000 |
| Other Non Current Liabilities | $68,673,000 | $63,551,000 | $71,910,000 | - |
| Derivative Product Liabilities | $491,910,000 | $690,567,000 | $801,147,000 | - |
| Tradeand Other Payables Non Current | $76,953,000 | $39,747,000 | $27,345,000 | $36,498,000 |
| Non Current Deferred Liabilities | $742,908,000 | $764,158,000 | $945,949,000 | $868,452,000 |
| Non Current Deferred Taxes Liabilities | $708,890,000 | $750,286,000 | $936,475,000 | $868,452,000 |
| Current Liabilities | $5,660,060,000 | $6,111,590,000 | $6,467,314,000 | $7,257,634,000 |
| Other Current Liabilities | $1,664,919,000 | $1,847,273,000 | $1,779,932,000 | $1,659,753,000 |
| Current Deferred Liabilities | $82,165,000 | $85,819,000 | $105,721,000 | $518,031,000 |
| Payables And Accrued Expenses | $1,520,064,000 | $1,478,917,000 | $1,486,813,000 | $1,402,187,000 |
| Payables | $1,268,084,000 | $1,228,095,000 | $1,224,245,000 | $1,132,378,000 |
| Other Payable | $1,127,000 | $11,085,000 | $4,794,000 | $9,721,000 |
| Total Tax Payable | $282,635,000 | $331,861,000 | $267,867,000 | $265,131,000 |
| Income Tax Payable | $142,654,000 | $191,265,000 | $143,932,000 | $137,836,000 |
| Accounts Payable | $984,322,000 | $885,149,000 | $951,584,000 | $857,526,000 |
| Interest Payable | - | - | $58,266,000 | $68,558,000 |
| Equity | ||||
| Common Stock Equity | $14,576,563,000 | $13,620,261,000 | $13,989,453,000 | $12,698,783,000 |
| Total Equity Gross Minority Interest | $15,768,513,000 | $14,826,535,000 | $15,449,179,000 | $13,979,037,000 |
| Stockholders Equity | $14,576,563,000 | $13,620,261,000 | $13,989,453,000 | $12,698,783,000 |
| Gains Losses Not Affecting Retained Earnings | $-328,545,000 | $-975,169,000 | $-388,468,000 | $-1,311,637,000 |
| Other Equity Adjustments | $-328,545,000 | $-975,169,000 | $-388,468,000 | $-1,311,637,000 |
| Retained Earnings | $11,266,287,000 | $10,921,686,000 | $10,711,709,000 | $10,826,140,000 |
| Long Term Equity Investment | $620,831,000 | $642,928,000 | $773,724,000 | $786,905,000 |
| Investments In Other Ventures Under Equity Method | - | $754,515,000 | $717,267,000 | - |
| Other | ||||
| Ordinary Shares Number | $293,413,449 | $293,413,449 | $293,413,449 | $293,004,339 |
| Share Issued | $293,413,449 | $293,413,449 | $293,413,449 | $293,004,339 |
| Tangible Book Value | $-1,964,169,000 | $-2,392,074,000 | $-3,320,405,000 | $-3,122,187,000 |
| Invested Capital | $21,414,770,000 | $21,524,727,000 | $22,503,016,000 | $21,269,551,000 |
| Working Capital | $2,262,684,000 | $2,589,821,000 | $1,736,141,000 | $709,608,000 |
| Capital Lease Obligations | $4,140,701,000 | $4,145,946,000 | $4,678,763,000 | $4,749,381,000 |
| Total Capitalization | $20,837,388,000 | $20,580,124,000 | $21,160,187,000 | $19,345,732,000 |
| Minority Interest | $1,191,950,000 | $1,206,274,000 | $1,459,726,000 | $1,280,254,000 |
| Additional Paid In Capital | $3,345,408,000 | $3,380,331,000 | $3,372,799,000 | $2,891,276,000 |
| Capital Stock | $293,413,000 | $293,413,000 | $293,413,000 | $293,004,000 |
| Common Stock | $293,413,000 | $293,413,000 | $293,413,000 | $293,004,000 |
| Employee Benefits | $800,404,000 | $769,513,000 | $620,128,000 | $782,622,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $678,673,000 | $664,327,000 | $514,219,000 | $782,622,000 |
| Non Current Deferred Revenue | $34,018,000 | $13,872,000 | $9,474,000 | - |
| Long Term Capital Lease Obligation | $3,499,817,000 | $3,528,987,000 | $4,004,938,000 | $4,087,803,000 |
| Long Term Provisions | $196,516,000 | $175,297,000 | $195,470,000 | $707,563,000 |
| Current Deferred Revenue | $82,165,000 | $85,819,000 | $105,721,000 | $518,031,000 |
| Current Capital Lease Obligation | $640,884,000 | $616,959,000 | $673,825,000 | $661,578,000 |
| Line Of Credit | $1,941,000 | $57,754,000 | $149,265,000 | $463,091,000 |
| Commercial Paper | $0 | $399,078,000 | $495,424,000 | $715,153,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $726,278,000 | $713,409,000 | $707,398,000 | $746,743,000 |
| Current Provisions | $448,368,000 | $424,610,000 | $370,796,000 | $345,523,000 |
| Current Accrued Expenses | $251,980,000 | $250,822,000 | $262,568,000 | $269,809,000 |
| Investments And Advances | $1,416,687,000 | $1,254,512,000 | $1,389,520,000 | $786,905,000 |
| Held To Maturity Securities | $316,071,000 | $284,102,000 | $274,821,000 | - |
| Available For Sale Securities | $479,785,000 | $327,482,000 | $340,975,000 | - |
| Goodwill | $15,170,652,000 | $14,650,008,000 | $15,791,181,000 | $14,361,577,000 |
| Net PPE | $7,258,582,000 | $7,454,021,000 | $8,339,808,000 | $8,551,467,000 |
| Accumulated Depreciation | $-11,530,924,000 | $-10,452,145,000 | $-9,898,528,000 | $-8,102,863,000 |
| Gross PPE | $18,789,506,000 | $17,906,166,000 | $18,238,336,000 | $16,654,330,000 |
| Leases | $7,108,897,000 | $6,557,178,000 | $6,610,406,000 | $5,952,476,000 |
| Construction In Progress | $385,659,000 | $384,052,000 | $362,838,000 | $394,333,000 |
| Other Properties | $193,265,000 | $324,167,000 | $330,900,000 | $389,894,000 |
| Machinery Furniture Equipment | $6,417,147,000 | $6,227,695,000 | $6,400,316,000 | $5,679,662,000 |
| Buildings And Improvements | $4,580,202,000 | $4,306,223,000 | $4,424,685,000 | $4,129,180,000 |
| Land And Improvements | $104,336,000 | $106,851,000 | $109,191,000 | $108,785,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,182,034,000 | $1,232,702,000 | $1,310,995,000 | $1,233,197,000 |
| Work In Process | $124,102,000 | $133,353,000 | $124,404,000 | $105,266,000 |
| Raw Materials | $761,786,000 | $813,120,000 | $860,815,000 | $699,551,000 |
| Duefrom Related Parties Current | $40,936,000 | $165,299,000 | $140,072,000 | $162,361,000 |
| Other Short Term Investments | $295,629,000 | $136,286,000 | $154,876,000 | $136,362,000 |
| Treasury Shares Number | - | $0 | - | - |
| Investmentsin Associatesat Cost | - | $41,595,000 | $56,457,000 | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,686,786,000 | $1,944,205,000 | $1,443,391,000 | $1,635,138,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,386,144,000 | $2,628,801,000 | $2,167,379,000 | $2,489,498,000 |
| Cash Flow From Continuing Operating Activities | $2,386,144,000 | $2,628,801,000 | $2,167,379,000 | $2,489,498,000 |
| Operating Gains Losses | $-147,043,000 | $-134,687,000 | $-165,827,000 | $-48,087,000 |
| Investing Activities | ||||
| Capital Expenditure | $-699,358,000 | $-684,596,000 | $-723,988,000 | $-854,360,000 |
| Investing Cash Flow | $-84,939,000 | $-544,227,000 | $-734,725,000 | $-1,196,228,000 |
| Cash Flow From Continuing Investing Activities | $-84,939,000 | $-544,227,000 | $-734,725,000 | $-1,196,228,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-2,569,300,000 | $-1,858,529,000 | $-1,617,360,000 | $-1,024,382,000 |
| Cash Flow From Continuing Financing Activities | $-2,569,300,000 | $-1,858,529,000 | $-1,617,360,000 | $-1,024,382,000 |
| Net Other Financing Charges | $-314,989,000 | $-340,113,000 | $-123,950,000 | $-279,535,000 |
| Cash Dividends Paid | $-349,162,000 | $-328,623,000 | $-395,556,000 | $-392,455,000 |
| Dividend Received Cfo | $100,663,000 | $219,953,000 | $95,213,000 | $58,472,000 |
| Repurchase Of Capital Stock | - | - | $0 | $0 |
| Common Stock Dividend Paid | - | - | $-395,556,000 | $-392,455,000 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-2,051,474,000 | $-1,673,007,000 | $-2,822,023,000 | $-3,407,204,000 |
| Issuance Of Debt | $146,325,000 | $483,214,000 | $1,704,016,000 | $3,048,301,000 |
| End Cash Position | $1,185,328,000 | $1,427,225,000 | $1,273,787,000 | $1,481,655,000 |
| Beginning Cash Position | $1,427,225,000 | $1,273,787,000 | $1,481,655,000 | $1,081,539,000 |
| Effect Of Exchange Rate Changes | $26,198,000 | $-72,607,000 | $-23,162,000 | $131,228,000 |
| Changes In Cash | $-268,095,000 | $226,045,000 | $-184,706,000 | $268,888,000 |
| Proceeds From Stock Option Exercised | $0 | $0 | $20,153,000 | $6,511,000 |
| Net Issuance Payments Of Debt | $-1,905,149,000 | $-1,189,793,000 | $-1,118,007,000 | $-358,903,000 |
| Net Short Term Debt Issuance | $-455,687,000 | $-179,638,000 | $-585,157,000 | $1,176,957,000 |
| Short Term Debt Payments | $-540,499,000 | $-244,975,000 | $-1,302,251,000 | $-627,250,000 |
| Short Term Debt Issuance | $84,812,000 | $65,337,000 | $717,094,000 | $1,804,207,000 |
| Net Long Term Debt Issuance | $-1,449,462,000 | $-1,010,155,000 | $-532,850,000 | $-1,535,860,000 |
| Long Term Debt Payments | $-1,510,975,000 | $-1,428,032,000 | $-1,519,772,000 | $-2,779,954,000 |
| Long Term Debt Issuance | $61,513,000 | $417,877,000 | $986,922,000 | $1,244,094,000 |
| Net Investment Purchase And Sale | $-6,367,000 | $-12,768,000 | $-47,970,000 | $15,435,000 |
| Sale Of Investment | $75,134,000 | $89,595,000 | $57,671,000 | $144,516,000 |
| Purchase Of Investment | $-81,501,000 | $-102,363,000 | $-105,641,000 | $-129,081,000 |
| Net Business Purchase And Sale | $606,683,000 | $136,999,000 | $1,028,000 | $-381,727,000 |
| Sale Of Business | $629,749,000 | $172,201,000 | $60,161,000 | $52,444,000 |
| Purchase Of Business | $-23,066,000 | $-35,202,000 | $-59,133,000 | $-434,171,000 |
| Net PPE Purchase And Sale | $-685,255,000 | $-668,458,000 | $-687,783,000 | $-829,936,000 |
| Sale Of PPE | $14,103,000 | $16,138,000 | $36,205,000 | $24,424,000 |
| Purchase Of PPE | $-699,358,000 | $-684,596,000 | $-723,988,000 | $-854,360,000 |
| Taxes Refund Paid | $-444,586,000 | $-410,126,000 | $-334,615,000 | $-345,052,000 |
| Interest Received Cfo | $68,099,000 | $88,217,000 | $67,663,000 | $73,170,000 |
| Interest Paid Cfo | $-381,226,000 | $-394,535,000 | $-350,681,000 | $-341,629,000 |
| Change In Working Capital | $444,313,000 | $561,276,000 | $-128,067,000 | $-97,768,000 |
| Change In Other Current Assets | $-227,970,000 | $145,697,000 | $154,031,000 | $164,201,000 |
| Change In Payables And Accrued Expense | $637,863,000 | $580,563,000 | $-31,109,000 | $-50,242,000 |
| Change In Payable | $637,863,000 | $580,563,000 | $-31,109,000 | $-50,242,000 |
| Change In Account Payable | $155,589,000 | $108,479,000 | $-356,789,000 | $-363,955,000 |
| Change In Tax Payable | $482,274,000 | $472,084,000 | $325,680,000 | $313,713,000 |
| Change In Income Tax Payable | $482,274,000 | $472,084,000 | $325,680,000 | $313,713,000 |
| Change In Inventory | $107,897,000 | $-13,140,000 | $-204,307,000 | $-48,530,000 |
| Change In Receivables | $-73,477,000 | $-151,844,000 | $-46,682,000 | $-163,197,000 |
| Changes In Account Receivables | $-73,477,000 | $-151,844,000 | $-46,682,000 | $-163,197,000 |
| Other Non Cash Items | $335,469,000 | $336,423,000 | $292,476,000 | $280,429,000 |
| Deferred Tax | $-72,672,000 | $-122,149,000 | $-41,471,000 | $67,259,000 |
| Deferred Income Tax | $-72,672,000 | $-122,149,000 | $-41,471,000 | $67,259,000 |
| Depreciation Amortization Depletion | $1,742,257,000 | $1,751,971,000 | $1,838,363,000 | $1,623,676,000 |
| Depreciation And Amortization | $1,742,257,000 | $1,751,971,000 | $1,838,363,000 | $1,623,676,000 |
| Depreciation | $1,742,257,000 | $1,751,971,000 | $1,838,363,000 | $1,623,676,000 |
| Earnings Losses From Equity Investments | $-134,875,000 | $-121,785,000 | $-66,559,000 | $-92,175,000 |
| Gain Loss On Sale Of PPE | $-12,168,000 | $-12,902,000 | $-99,268,000 | $44,088,000 |
| Net Income From Continuing Operations | $740,870,000 | $732,458,000 | $894,325,000 | $1,219,028,000 |
| Common Stock Payments | - | - | $0 | $0 |
| Stock Based Compensation | - | - | - | $0 |
Fetched: 2026-02-02